Evidence map›Paper›PMID 29110353›Full record

ArticleInternational journal of geriatric psychiatry2018

Amotivation is associated with smaller ventral striatum volumes in older patients with schizophrenia.

Fernando Caravaggio, Gagan Fervaha, Yusuke Iwata, Eric Plitman, Jun Ku Chung, Shinichiro Nakajima, Wanna Mar, Philip Gerretsen, Julia Kim, M Mallar Chakravarty and 5 more

Abstract read
In one paragraph

Article in International journal of geriatric psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fernando CaravaggioResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.ORCID 0000-0002-9048-4963
Gagan FervahaResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Yusuke IwataResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Eric PlitmanResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Jun Ku ChungResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Shinichiro NakajimaResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Wanna MarResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Philip GerretsenResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Julia KimResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
M Mallar ChakravartyDepartment of Biological & Biomedical Engineering, McGill University, Montreal, Quebec, Canada.
Benoit MulsantDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Bruce PollockDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
David MamoDepartment of Psychiatry, University of Malta, Msida, Malta.
Gary RemingtonResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Ariel Graff-GuerreroResearch Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

Funding

Optimal Dosing of Antipsychotic Drugs in Late LifeR01MH084886 · NIMH · CENTRE FOR ADDICTION AND MENTAL HEALTH · PI MAMO, DAVID · 2010 to 2014
$761k
CIHR MOP‐97946NIMH NIH HHS R01 MH084886
6 · The paper itself

Abstract

objectiveMotivational deficits are prevalent in patients with schizophrenia, persist despite antipsychotic treatment, and predict long-term outcomes. Evidence suggests that patients with greater amotivation have smaller ventral striatum (VS) volumes. We wished to replicate this finding in a sample of older, chronically medicated patients with schizophrenia. Using structural imaging and positron emission tomography, we examined whether amotivation uniquely predicted VS volumes beyond the effects of striatal dopamine D

methodsData from 41 older schizophrenia patients (mean age: 60.2 ± 6.7; 11 female) were reanalysed from previously published imaging data. We constructed multivariate linear stepwise regression models with VS volumes as the dependent variable and various sociodemographic and clinical variables as the initial predictors: age, gender, total brain volume, and antipsychotic striatal D

resultsAmotivation uniquely explained 8% and 6% of the variance in right and left VS volumes, respectively (right: β = -.38, t = -2.48, P = .01; left: β = -.31, t = -2.17, P = .03). Considering cognition, amotivation levels uniquely explained 9% of the variance in right VS volumes (β = -.43, t = -0.26, P = .03).

conclusionWe replicate and extend the finding of reduced VS volumes with greater amotivation. We demonstrate this relationship uniquely beyond the potential contributions of striatal D

Indexed as

Schizophrenic PsychologyAgedAntipsychotic AgentsFemaleHumansMaleMiddle AgedMotivationPositron-Emission TomographyReceptors, Dopamine D2Regression AnalysisSchizophreniaVentral StriatumAntipsychotic AgentsReceptors, Dopamine D2accumbensamotivationapathyD2/3 receptordopaminemorphologymotivationoccupancyschizophreniaventral striatum

Identifiers

PMID29110353
PMCPMC5807115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.